The Study of Voriconazole Trough Level in the First Two Weeks After Administration in King Chulalongkorn Memorial Hospital.

Clinical Trial ID NCT03260634

Rank	Title	Journal	Year	PubWeight™‹?›
1	Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.	Clin Infect Dis	2008	5.39
2	Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities.	J Clin Pharmacol	2006	1.88
3	The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial.	Clin Infect Dis	2012	1.76
4	Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.	Clin Infect Dis	2016	1.58
5	Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders.	Int J Hematol	2009	1.19
6	Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.	J Infect Chemother	2013	0.87